Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: drug reintroduction can be successful.
CHU Hôtel-Dieu, service de médecine interne, 44093 Nantes, France.
François
F
Perrin
CHU Hôtel-Dieu, service de médecine interne, 44093 Nantes, France. Electronic address: antoine.neel@univ-nantes.fr.
Antoine
A
Néel
CHU Hôtel-Dieu, service de médecine interne, 44093 Nantes, France.
Julie
J
Graveleau
CHU Hôtel-Dieu, centre régional de pharmacovigilance, 44093 Nantes, France.
Anne-Lise
AL
Ruellan
CHU Hôtel-Dieu, service de médecine interne, 44093 Nantes, France.
Agathe
A
Masseau
CHU Hôtel-Dieu, service de médecine interne, 44093 Nantes, France.
Mohamed
M
Hamidou
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D019873:Schnitzler Syndrome / Q000188:drug therapy*; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein